loadpatents
Patent applications and USPTO patent grants for Hruza; Alan.The latest application filed is for "compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease".
Patent | Date |
---|---|
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease Grant 10,414,774 - Cumming , et al. Sept | 2019-09-17 |
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease Grant 10,414,775 - Caldwell , et al. Sept | 2019-09-17 |
Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease App 20190218223 - Cumming; Jared N. ;   et al. | 2019-07-18 |
Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease App 20190218224 - Caldwell; John P. ;   et al. | 2019-07-18 |
Factor IXa inhibitors Grant 10,189,819 - Zhang , et al. Ja | 2019-01-29 |
Factor XIa inhibitors Grant 10,123,995 - Mertz , et al. November 13, 2 | 2018-11-13 |
Factor XIa inhibitors Grant 10,081,617 - Mertz , et al. September 25, 2 | 2018-09-25 |
Factor XIa inhibitors Grant 10,011,585 - Liu , et al. July 3, 2 | 2018-07-03 |
Factor XIa inhibitors Grant 9,975,874 - Mertz , et al. May 22, 2 | 2018-05-22 |
FACTOR XIa INHIBITORS App 20180079743 - Mertz; Eric ;   et al. | 2018-03-22 |
Factor IXa Inhibitors App 20180030036 - Zhang; Ting ;   et al. | 2018-02-01 |
FACTOR XIa INHIBITORS App 20180000795 - Mertz; Eric ;   et al. | 2018-01-04 |
FACTOR XIa INHIBITORS App 20170240523 - Liu; Weiguo ;   et al. | 2017-08-24 |
Factor XIa Inhibitors App 20170240524 - Mertz; Eric ;   et al. | 2017-08-24 |
Compounds that are ERK inhibitors Grant 7,807,672 - Deng , et al. October 5, 2 | 2010-10-05 |
Novel compounds that are ERK inhibitors App 20070232610 - Deng; Yongqi ;   et al. | 2007-10-04 |
Method for producing metal-interferon-.alpha. crystals Grant 5,602,232 - Reichert , et al. February 11, 1 | 1997-02-11 |
Metal-interferon-alpha crystals Grant 5,441,734 - Reichert , et al. August 15, 1 | 1995-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.